We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+49.2%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.41B
AUM Growth
Cap. Flow
+$1.21B
Cap. Flow %
85.7%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$1.21B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.41B 100%
+27,084,525
New +$1.21B

Similar funds

Crestline Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Crestline Management, which disclosed 1 position worth $1.41B. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Juno Therapeutics, Inc.: 27,084,525 shares worth $1.41B.

  • Crestline Management's largest Q4 2014 buy was Juno Therapeutics, Inc.: 27,084,525 shares worth $1.41B.
  • Crestline Management's ten largest holdings make up 100% of its $1.41B portfolio in Q4 2014.
  • Crestline Management disclosed 1 position in Q4 2014, its first 13F filing on record.

Based on Crestline Management's 13F filing for Q4 2014, filed 14 Jul 2015.